Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord. SE CONNECTER À UN COMPTE LECTEUR CRÉER UN COMPTE LECTEUR
Dyadic Reports Second Quarter 2022 Financial Results and Highlights Recent Company Developments
10 août 2022 16h00 HE
|
Dyadic International, Inc.
Submission of a Clinical Trial Application (CTA) with South African Health Products Regulatory Authority (SAHPRA) to initiate a Phase 1 study to support clinical safety of proteins produced from...
iHealth Donates 1-Million A-Home Tests to the State of California
25 juil. 2022 08h12 HE
|
iHealth Labs Inc
SAN JOSE, Calif., July 25, 2022 (GLOBE NEWSWIRE) -- iHealth Labs, Inc., one of the major suppliers of at-home COVID tests in the U.S. market, is donating 1 million at-home COVID tests to the State...
Achiko AG – Investor Briefing
07 juil. 2022 15h22 HE
|
Achiko AG
ZURICH, Switzerland, July 07, 2022 (GLOBE NEWSWIRE) -- Achiko AG (OTCQB: ACHKF, SIX: ACHI, ISIN CH0522213468) (“Achiko”, the “Company”), would like to invite investors and shareholders to a...
Dyadic to Participate in Bio-Manufacturing Innovation Summit and NIIMBL National Meeting
05 juil. 2022 08h30 HE
|
Dyadic International, Inc.
JUPITER, Fla., July 05, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on further improving, applying and...
Pfizer and BioNTech Announce New Agreement with U.S. Government to Provide Additional Doses of COVID-19 Vaccine
29 juin 2022 16h45 HE
|
BioNTech SE
105 million 30 µg, 10 µg and 3 µg doses to be delivered into Q4 2022, with an option for the U.S. Government to purchase up to 195 million additional doses NEW YORK and MAINZ, GERMANY, JUNE...
Pfizer und BioNTech schließen neue Liefervereinbarung mit der US-Regierung für zusätzliche Dosen des COVID-19-Impfstoffs
29 juin 2022 16h45 HE
|
BioNTech SE
Liefervereinbarung umfasst 105 Millionen 30 µg-, 10 µg- sowie 3 µg-Dosen, die bis einschließlich des vierten Quartals 2022 geliefert werden sollen; die US-Regierung hat die Option, 195 Millionen...
Pfizer and BioNTech Announce Omicron-Adapted COVID-19 Vaccine Candidates Demonstrate High Immune Response Against Omicron
25 juin 2022 10h02 HE
|
BioNTech SE
Omicron-adapted monovalent candidate given as a fourth booster dose elicited a 13.5 and 19.6-fold increase in neutralizing geometric titers against Omicron BA.1 at 30 µg and 60 µg dose levels;...
Achiko AG – Publication of Annual Report and Annual Financial Statements 2021 to Occur by June 26, 2022
20 juin 2022 20h24 HE
|
Achiko AG
ZURICH, Switzerland, June 20, 2022 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (SIX: ACHI; OTCQB: ACHKF; ISIN CH0522213468) (“Achiko”, the “Company”) announces that...
Dyadic to Present at 2022 Jefferies Healthcare Conference
02 juin 2022 09h27 HE
|
Dyadic International, Inc.
JUPITER, Fla., June 02, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on further improving, applying and...
Achiko AG Publication of Annual Report and Annual Financial Statements 2021 to Occur by June 6, 2022
31 mai 2022 07h30 HE
|
Achiko AG
ZURICH, Switzerland, May 31, 2022 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (OTCQB: ACHKF; SIX: ACHI; ISIN CH0522213468) (“Achiko”, the “Company”) announces that...